Innovation Pharmaceuticals Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease

NEXT STORY
Global Point-of-Care Diagnostics, Health & Biosensors Conference 2019: POC Testing Landscape, Novel Technologies to Regulatory Approval (San Diego, CA, United States – October 7-9, 2019)
PREV STORY
Three-Year Clinical Trial Results Support ILUVIEN® Launch in Europe for the Prevention of Relapse in Recurrent Non-Infectious Uveitis Affecting the Posterior Segment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

author_avatar
NASDAQ Market News

Global MRI systems market size to raise exponentially through 2026

author_avatar
NASDAQ Market News

Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine

author_avatar
NASDAQ Market News